Imaging Biometrics Ltd. (FRA:5Y1)

Market Cap	2.42M
Revenue (ttm)	816.46K
Net Income (ttm)	-166.18K
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,425
Average Volume	521
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0170
Beta	n/a
RSI	47.93
Earnings Date	May 1, 2026

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routin...

• Industry: Prepackaged Software
• Founded: 1965
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5Y1

Financial Performance

In 2024, Imaging Biometrics's revenue was 750,105, an increase of 23.09% compared to the previous year's 609,390. Losses were -327,103, -47.56% less than in 2023.

Financial numbers in GBP